BAYRY BAYER AG S/ADR Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
08:30
Jun 01
Reuters Business Newswire (@ReutersBiz)
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons from the acquisition.
BAYRY
06:15
Jun 01
Reuters Business Newswire (@ReutersBiz)
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons from the acquisition.
BAYRY
17:14
Mar 04
@business
Bayer said a US judge granted preliminary approval for its $7.25 billion settlement proposal aimed at containing its liability from thousands of lawsuits over Roundup weedkiller, which have weighed on the German company for years. https://t.co/3PGGrHg0vV
BAYRY
16:36
Feb 26
@FirstSquawk
Positive Phase 3 trial data for a key drug combination is a significant fundamental catalyst that should drive the stock price higher.
BAYRY
MED
21:43
Feb 18
@FirstSquawk
Bayer faces significant headwinds as its Roundup settlement is met with skepticism, coupled with a direct company warning of negative cash flow and ongoing litigation risk.
BAYRY
MED

About BAYRY Analyst Coverage

Buzzberg tracks BAYRY (BAYER AG S/ADR) across 3 sources. 0 bullish vs 0 bearish calls from 3 analysts. Sentiment: evenly split. 5 total trade ideas tracked.